Exploring cocoa properties: is theobromine a cognitive modulator?


Journal

Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 07 05 2018
accepted: 16 01 2019
pubmed: 2 2 2019
medline: 8 5 2019
entrez: 2 2 2019
Statut: ppublish

Résumé

Nutritional qualities of cocoa have been acknowledged by several authors; a particular focus has been placed on its high content of flavanols, known for their excellent antioxidant properties and subsequent protective effect on cardio- and cerebrovascular systems as well as for neuromodulatory and neuroprotective actions. Other active components of cocoa are methylxanthines (caffeine and theobromine). Whereas the effects of caffeine are extensively researched, the same is not the case for theobromine; this review summarizes evidence on the effect of theobromine on cognitive functions. Considering animal studies, it can be asserted that acute exposition to theobromine has a reduced and delayed nootropic effect with respect to caffeine, whereas both animal and human studies suggested a potential neuroprotective action of long-term assumption of theobromine through a reduction of Aβ amyloid pathology, which is commonly observed in Alzheimer's disease patients' brains. Hence, the conceivable action of theobromine alone and associated with caffeine or other cocoa constituents on cognitive modulation is yet underexplored and future studies are needed to shed light on this promising molecule.

Identifiants

pubmed: 30706099
doi: 10.1007/s00213-019-5172-0
pii: 10.1007/s00213-019-5172-0
doi:

Substances chimiques

Amyloid beta-Peptides 0
Central Nervous System Stimulants 0
Nootropic Agents 0
Polyphenols 0
Caffeine 3G6A5W338E
Theobromine OBD445WZ5P

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-572

Références

J Neurosci. 1999 May 15;19(10):4011-22
pubmed: 10234030
Cell Mol Neurobiol. 1999 Dec;19(6):719-32
pubmed: 10456233
J Am Diet Assoc. 1999 Oct;99(10):1249-56
pubmed: 10524390
Annu Rev Neurosci. 2001;24:31-55
pubmed: 11283304
J Allergy Clin Immunol. 2001 Nov;108(5):671-80
pubmed: 11692087
Psychopharmacology (Berl). 1979 Nov;65(3):299-309
pubmed: 117503
J Agric Food Chem. 1976 May-Jun;24(3):479-83
pubmed: 1270661
J Toxicol Sci. 1992 May;17(2):81-90
pubmed: 1507275
FASEB J. 2005 Feb;19(2):231-3
pubmed: 15548587
Psychopharmacology (Berl). 2004 Nov;176(3-4):412-9
pubmed: 15549276
J Immunol. 2005 Jan 15;174(2):589-94
pubmed: 15634873
Br J Pharmacol. 2005 Mar;144(5):642-50
pubmed: 15678095
Psychopharmacology (Berl). 2005 Aug;181(1):101-6
pubmed: 15772863
Biochem Pharmacol. 2006 Sep 28;72(7):902-10
pubmed: 16870158
Exp Neurol. 2007 Jan;203(1):241-5
pubmed: 17007839
J Am Soc Mass Spectrom. 2009 Jun;20(6):1037-47
pubmed: 19251438
Biosci Biotechnol Biochem. 2009 Apr 23;73(4):957-60
pubmed: 19352019
J Alzheimers Dis. 2009;18(4):849-65
pubmed: 19661617
Pharmacol Res. 2010 Jan;61(1):5-13
pubmed: 19735732
Biochem Pharmacol. 1977 Sep 15;26(18):1723-4
pubmed: 197971
Curr Neuropharmacol. 2009 Sep;7(3):207-16
pubmed: 20190962
Hypertension. 2010 Nov;56(5):839-46
pubmed: 20823377
Handb Exp Pharmacol. 2011;(200):201-34
pubmed: 20859797
Handb Exp Pharmacol. 2011;(200):235-50
pubmed: 20859798
Handb Exp Pharmacol. 2011;(200):267-310
pubmed: 20859800
Curr Top Med Chem. 2011;11(8):1012-33
pubmed: 21401498
Physiol Behav. 2011 Oct 24;104(5):816-22
pubmed: 21839757
Psychopharmacology (Berl). 2013 Jul;228(1):109-18
pubmed: 23420115
J Sci Food Agric. 2013 Aug 15;93(10):2596-604
pubmed: 23553798
J Clin Psychopharmacol. 2013 Aug;33(4):499-506
pubmed: 23764688
J Sci Food Agric. 2014 Apr;94(6):1042-56
pubmed: 24338740
Int J Mol Sci. 2014 Jan 28;15(2):2024-52
pubmed: 24477263
Nutr Cancer. 2014;66(3):419-23
pubmed: 24547961
J Intern Med. 2014 Mar;275(3):214-28
pubmed: 24605806
J Nutr Health Aging. 2015 Mar;19(3):313-28
pubmed: 25732217
Front Pharmacol. 2015 Feb 20;6:30
pubmed: 25750625
Food Funct. 2015 Apr;6(4):1251-60
pubmed: 25756794
J Alzheimers Dis. 2015;47(4):1069-78
pubmed: 26401784
Appetite. 2016 May 1;100:126-32
pubmed: 26873453
J Nutr Metab. 2016;2016:7906927
pubmed: 27144019
J Alzheimers Dis. 2016 Dec 6;55(3):1273-1283
pubmed: 27792010
J Nutr Biochem. 2017 Jan;39:110-116
pubmed: 27833051
Annu Rev Clin Psychol. 2017 May 8;13:369-396
pubmed: 28482688
Pharmacol Biochem Behav. 1986 Oct;25(4):769-73
pubmed: 3786337
J Allergy Clin Immunol. 1985 Nov;76(5):703-7
pubmed: 4056254
J Clin Pharmacol New Drugs. 1973 Apr;13(4):121-6
pubmed: 4487162
Clin Pharmacol Ther. 1970 Nov-Dec;11(6):869-72
pubmed: 5481573
Proc Natl Acad Sci U S A. 1981 May;78(5):3260-4
pubmed: 6265942
Br J Pharmacol. 1982 Mar;75(3):451-4
pubmed: 7066599
Psychopharmacology (Berl). 1994 Jun;115(1-2):1-8
pubmed: 7862879
Psychopharmacology (Berl). 1993;112(2-3):359-65
pubmed: 7871042
Eur J Clin Pharmacol. 1996;51(3-4):319-25
pubmed: 9010706

Auteurs

Ilaria Cova (I)

Center for Research and Treatment on Cognitive Dysfunctions, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi, 74, I-20157, Milan, Italy. ilaria.cova@unimi.it.

V Leta (V)

Center for Research and Treatment on Cognitive Dysfunctions, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi, 74, I-20157, Milan, Italy.
Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

C Mariani (C)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

L Pantoni (L)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

S Pomati (S)

Center for Research and Treatment on Cognitive Dysfunctions, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi, 74, I-20157, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH